A small but significant new study showed low doses of Ozempic helped people to drink less. Scientists are starting to ...
Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
but also for tobacco and alcohol. Scientists are studying these drugs in smokers, people with opioid addiction and cocaine users. “This is such promising data. And we need more of it,” said ...